Medtronic received information that at the end of the implant procedure of a 26mm transcatheter bioprosthetic valve, with this delivery catheter system (dcs) via right femoral artery access, a dissection was noted at the access site in the common femoral artery and 6mm above.The dissection was not flow limiting; a non-medtronic balloon-expandable stent was placed.It was reported that two non-medtronic closure devices and a non-medtronic introducer sheath were used during the valve implant procedure.Per the physician, it was very difficult to relate the dissection to a specific device; the most probable cause is the non-medtronic closure device, but a relationship with the dcs cannot be excluded.It was noted that a computed tomography scan performed prior to the valve implant showed an unspecified artery disease.No additional adverse patient effects were reported.
|